Works matching Multiple myeloma
Results: 5000
Akromegali ve Multiple Myeloma Birlikteliği: Bir Olgu Sunumu.
- Published in:
- Turkish Journal of Endocrinology & Metabolism, 2013, v. 17, n. 3, p. 75, doi. 10.4274/Tjem.2182
- By:
- Publication type:
- Article
Serum Level of Lactate Dehydrogenase is a Useful Clinical Marker to Monitor Progressive Multiple Myeloma Diseases: A Case Report.
- Published in:
- Turkish Journal of Hematology, 2014, v. 31, n. 1, p. 84, doi. 10.4274/Tjh.2012.0044
- By:
- Publication type:
- Article
Inhibition of apoptosis may lead to the development of bortezomib resistance in multiple myeloma cancer cells.
- Published in:
- Turkish Journal of Biochemistry / Turk Biyokimya Dergisi, 2021, v. 46, n. 1, p. 63, doi. 10.1515/tjb-2019-0521
- By:
- Publication type:
- Article
Circulating Multiple Myeloma Cells (CMMCs) as Prognostic and Predictive Markers in Multiple Myeloma and Smouldering MM Patients.
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 2929, doi. 10.3390/cancers16172929
- By:
- Publication type:
- Article
Comparison of clinical and laboratory characteristics of nonsecretory multiple myeloma and secretory multiple myeloma in a tertiary care hospital.
- Published in:
- International Journal of Laboratory Hematology, 2022, v. 44, n. 3, p. 582, doi. 10.1111/ijlh.13811
- By:
- Publication type:
- Article
祛瘀散结汤联合BRD治疗多发性骨髓瘤患者的疗效及机制探究.
- Published in:
- Progress in Modern Biomedicine, 2021, v. 21, n. 3, p. 498, doi. 10.13241/j.cnki.pmb.2021.03.020
- By:
- Publication type:
- Article
Recomendações do Grupo Português do Mieloma Múltiplo para Tratamento do Mieloma Múltiplo.
- Published in:
- Acta Médica Portuguesa, 2023, v. 36, n. 7/8, p. 517, doi. 10.20344/amp.19037
- By:
- Publication type:
- Article
Investigation of ErbB and Insulin Signaling Pathways in the Pathogenesis of Multiple Myeloma.
- Published in:
- Medical Bulletin of Haseki / Haseki Tip Bulteni, 2018, v. 56, n. 2, p. 109, doi. 10.4274/haseki.30502
- By:
- Publication type:
- Article
健康教育护理联合叙事护理模式对多发性骨髓瘤患者 护理效果的影响.
- Published in:
- Journal of Clinical Nursing in Practice, 2023, v. 9, n. 9, p. 49, doi. 10.11997/nitcwm.202309013
- By:
- Publication type:
- Article
Galectin-8 enhances adhesion of multiple myeloma cells to vascular endothelium and is an adverse prognostic factor.
- Published in:
- Glycobiology, 2016, v. 26, n. 10, p. 1048, doi. 10.1093/glycob/cww066
- By:
- Publication type:
- Article
Plasma Cell Immunophenotyping Improve Prognostic Stratification of Multiple Myeloma Patients.
- Published in:
- International Journal of Cancer Management, 2018, v. 11, n. 1, p. 1, doi. 10.5812/ijcm.5350
- By:
- Publication type:
- Article
An observational study assessing peripheral neuropathy related to multiple myeloma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Vaccination in Multiple Myeloma: Review of Current Literature.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The Danish National Multiple Myeloma Registry.
- Published in:
- Clinical Epidemiology, 2016, v. 8, p. 583, doi. 10.2147/CLEP.S99463
- By:
- Publication type:
- Article
Realistic Lenalidomide Dose Adjustment Strategy for Transplant-Ineligible Elderly Patients with Relapsed/Refractory Multiple Myeloma: Japanese Real-World Experience.
- Published in:
- Acta Haematologica, 2017, v. 138, n. 1, p. 55, doi. 10.1159/000477792
- By:
- Publication type:
- Article
Mieloma múltiple asociado con hiperbetaglobulinemia en paciente cirrótico. Reporte de caso.
- Published in:
- Revista Ciencias de la Salud, 2019, v. 17, n. 3, p. 132, doi. 10.12804/revistas.urosario.edu.co/revsalud/a.8370
- By:
- Publication type:
- Article
Adherence to immunomodulatory drugs in patients with multiple myeloma.
- Published in:
- PLoS ONE, 2019, v. 14, n. 3, p. 1, doi. 10.1371/journal.pone.0214446
- By:
- Publication type:
- Article
Images of the month 2: Gastrointestinal bleeding with a large liver and a small spleen: a rare appearance of multiple myeloma.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
- Published in:
- International Journal of Laboratory Hematology, 2016, v. 38, p. 110, doi. 10.1111/ijlh.12504
- By:
- Publication type:
- Article
Atypical IgM multiple myeloma with deletion of c- MAF.
- Published in:
- International Journal of Laboratory Hematology, 2015, v. 37, n. 5, p. 686, doi. 10.1111/ijlh.12385
- By:
- Publication type:
- Article
Identification of ID-1 as a potential target gene of MMSET in multiple myeloma.
- Published in:
- British Journal of Haematology, 2005, v. 130, n. 5, p. 700, doi. 10.1111/j.1365-2141.2005.05664.x
- By:
- Publication type:
- Article
Comparative genomic hybridisation identifies two variants of smoldering multiple myeloma.
- Published in:
- British Journal of Haematology, 2005, v. 130, n. 5, p. 729, doi. 10.1111/j.1365-2141.2005.05673.x
- By:
- Publication type:
- Article
Characteristics and survival trends in Finnish multiple myeloma patients-a nationwide real-world evidence study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Daratumumab in multiple myeloma: experience of the multiple myeloma GIMEMA Lazio group.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 4, p. 1059, doi. 10.1007/s00277-020-04374-y
- By:
- Publication type:
- Article
Serum-free light chains combined with the Revised International Staging System could further distinguish the superior and inferior clinical outcome of multiple myeloma patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clinical impact of the CONUT score in patients with multiple myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Observational study of multiple myeloma in Latin America.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Incidence and clinical background of hepatitis B virus reactivation in multiple myeloma in novel agents' era.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Prediction of patients with multiple myeloma eligible for second- or third-line treatment in France.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase 3 trial of three thalidomide-containing regimens in patients with newly diagnosed multiple myeloma not transplant-eligible.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Efficacy of a referral center for patient-centered care in multiple myeloma: a cohort study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Evaluation of low-dose thalidomide as induction and maintenance therapy in patients with multiple myeloma not eligible for stem cell transplantation.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2017, v. 13, n. 2, p. e138, doi. 10.1111/ajco.12418
- By:
- Publication type:
- Article
PROGRESSES AND CHALLENGES IN THE MANAGEMENT OF MULTIPLE MYELOMA: NAVIGATING THROUGH A RELAPSING-REMITTING COURSE.
- Published in:
- Acta Marisiensis. Seria Medica, 2024, v. 70, p. 194
- By:
- Publication type:
- Article
Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 12, p. 3541, doi. 10.3390/jcm11123541
- By:
- Publication type:
- Article
A voluminous mass as an initial clinical symptom of multiple myeloma: A case report.
- Published in:
- Experimental & Therapeutic Medicine, 2015, v. 10, n. 5, p. 1689, doi. 10.3892/etm.2015.2720
- By:
- Publication type:
- Article
ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma.
- Published in:
- Oncogene, 2005, v. 24, n. 46, p. 6936, doi. 10.1038/sj.onc.1208844
- By:
- Publication type:
- Article
Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back.
- Published in:
- CA: A Cancer Journal for Clinicians, 2014, v. 64, n. 6, p. 422, doi. 10.3322/caac.21252
- By:
- Publication type:
- Article
Detecting minimal residual disease in multiple myeloma: Challenges and prospects for the integration of novel approaches in clinical practice.
- Published in:
- Oncology Exchange, 2017, v. 16, n. 4, p. 14
- By:
- Publication type:
- Article
Phase II trial of daratumumab with DCEP in relapsed/refractory multiple myeloma patients with extramedullary disease.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01374-5
- By:
- Publication type:
- Article
Clinical Profile of Multiple Myeloma in South India.
- Published in:
- Indian Journal of Medical & Paediatric Oncology, 2018, v. 39, n. 1, p. 62, doi. 10.4103/ijmpo.ijmpo_57_17
- By:
- Publication type:
- Article
Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe).
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 5, p. 712, doi. 10.1007/s00259-017-3909-8
- By:
- Publication type:
- Article
The treatment of multiple myeloma by CAR-T cells: the problems and countermeasures.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 9, p. 791, doi. 10.3872/j.issn.1007-385x.2022.09.002
- By:
- Publication type:
- Article
Expression of WT1 gene in multiple myeloma patients at diagnosis: is WT1 gene expression a useful marker in multiple myeloma?
- Published in:
- Hematology, 2010, v. 15, n. 1, p. 39, doi. 10.1179/102453310X12583347009496
- By:
- Publication type:
- Article
The obesity paradox in multiple myeloma: A report from Multiple Myeloma Research Foundation (MMRF) dataset.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 23, p. 21400, doi. 10.1002/cam4.6685
- By:
- Publication type:
- Article
The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 7, p. 1807, doi. 10.1002/cam4.1128
- By:
- Publication type:
- Article
Renal impairment and use of nephrotoxic agents in patients with multiple myeloma in the clinical practice setting in the United States.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 7, p. 1523, doi. 10.1002/cam4.1075
- By:
- Publication type:
- Article
Bacteremias following autologous stem cell transplantation for multiple myeloma: Risk factors and outcomes.
- Published in:
- Transplant Infectious Disease, 2019, v. 21, n. 2, p. N.PAG, doi. 10.1111/tid.13052
- By:
- Publication type:
- Article
From guidelines to real world: results from the National Multiple Myeloma Registry in Uruguay on 222 newly diagnosed multiple myeloma patients from 2012 to 2015.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Risk Stratification of Precursors to Multiple Myeloma in 2020.
- Published in:
- Rhode Island Medical Journal, 2020, v. 103, n. 3, p. 46
- By:
- Publication type:
- Article